|
| Press Releases |
|
 |
|
| Tuesday, July 23, 2024 |
|
|
Avance Clinical Appoints Asia Regional Director as Part of Global Expansion Program |
| Avance Clinical, the award-winning CRO for biotechs, is proud to announce the appointment of Jessica Han as Director, Asian Operations based out of Avance Clinical's Seoul, Korea office. more info >> |
|
| Tuesday, June 4, 2024 |
|
|
New Research Launched at BIO24 Finds CROs with In-house Regulatory Affairs Can Deliver 30% Savings, Halve Timelines and Cut Risks for Biotechs |
| Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, is sharing new data at BIO 2024 from Frost & Sullivan research showing biotechs save more than 30% in costs and halve start-up times with CROs that have in-house scientific and regulatory affairs. more info >> |
|
| Friday, May 31, 2024 |
|
|
Avance Clinical Expands Specialist CNS, Cardiometabolic, and Rare Diseases CRO Services in Europe with Julius Clinical |
| Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs has signed a Memorandum of Understanding (MOU) with Julius Clinical, a leading CNS, cardiometabolic, and rare diseases specialist CRO with extensive site relationships in the region. more info >> |
|
| Wednesday, May 8, 2024 |
|
|
Avance Clinical Expands Further into APAC with New Clinical Operations in South Korea |
| Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, will attend BIO Korea (May 8-10, 2024) and formally open new clinical operations in Seoul, South Korea. more info >> |
|
| Friday, April 19, 2024 |
|
|
Avance Clinical Showcases Clinical Excellence at World Orphan Drug Conference in Boston, April 23-25 |
| Avance Clinical, the award-winning North American and Australian market-leading CRO for biotechs, will attend World Orphan Drug Conference in Boston (April 23-25, 2024) to share their rare diseases drug development expertise with biotechs (booth #730). more info >> |
|
| Thursday, March 28, 2024 |
|
|
Avance Clinical at World Vaccine Congress to Share Latest Vaccine Clinical Trial News Including an HIV-1 Study |
| Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, will attend World Vaccine Congress in Washington DC (April 1-4, 2024) and share the latest clinical trial client news including the Uvax Bio announcement. (Booth #267) more info >> |
|
| Wednesday, February 28, 2024 |
|
|
Avance Clinical CEO Talks with SCRIP about US Biotech Sector "Green Shoots" and a New CRO Report |
| Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, has today spoken with SCRIP about their positive outlook for the US biotech sector following the J.P. Morgan Healthcare Conference and Biotech Showcase meetings. (read the full article here) more info >> |
|
| Friday, January 12, 2024 |
|
|
Latest Analysis Reveals 65% of US Biotechs Struggle to Identify Suitable CRO Partner |
| Avance Clinical, the leading Australian and North American CRO for biotechs announced today that new industry analysis shows 60-65% of US biotechs face challenges identifying the right sized CRO partner that can deliver at every phase of their drug development program. The report found this directly affected clinical programs and budgets. more info >> |
|
| Thursday, October 19, 2023 |
|
|
Avance Clinical Invited to Brief 45 Korean Biotechs on Their GlobalReady Drug Development Pathway from Korea and Australia to the US |
| more info >> |
|
| Tuesday, May 30, 2023 |
|
|
Avance Clinical at ASCO & BIO 2023: Early Phase Oncology Trials Increasingly Elaborate and Demand More Patients |
| Avance Clinical, the leading award-winning Australian and North American CRO that offers ClinicReady and GlobalReady for early phase biotech companies to speed up the path to regulatory approval, says early phase oncology studies are increasingly more complex and demand more patients. more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
TransNusa Signs Agreement with Three Renowned Medical Centres in Malaysia 
Oct 22, 2024 11:00 HKT/SGT
|
|
|
Global Technology Distribution Council Welcomes Redington Limited
Oct 22, 2024 08:00 HKT/SGT
|
|
|
Femto Technologies Inc. Announces Consolidation of Enhanced Voting Preference Shares
Oct 22, 2024 08:00 HKT/SGT
|
|
|
Acrometa Group to Divest Its Life Sciences Business, Pursue New Business Opportunities in the Region
Oct 21, 2024 22:50 HKT/SGT
|
|
|
GMG Provides Business Update on Australian Federal Government Engagement
Oct 21, 2024 20:29 HKT/SGT
|
|
|
Hong Kong International Wine & Spirits Fair opens next month
Oct 21, 2024 19:39 HKT/SGT
|
|
|
FishWar Officially Powered by Sei: Elevating the GameFi Experience
Oct 21, 2024 19:00 HKT/SGT
|
|
|
Majority of Singapore Employees Comfortable Discussing Mental Health at Work, foundit Survey Reveals
Oct 21, 2024 16:00 HKT/SGT
|
|
|
GTJAI Wins Multiple Awards at HKQAA Hong Kong Green and Sustainable Finance Awards 2024
Oct 21, 2024 15:48 HKT/SGT
|
|
|
Learn & Get Inspired at the Global STEM Confex
Oct 21, 2024 15:00 HKT/SGT
|
|
|
TOYOTA GAZOO Racing closes the gap before the final round
Oct 21, 2024 13:27 JST
|
|
|
Everest Medicines Announces Taiwan TFDA Approval of NEFECON for the Treatment of Primary IgA Nephropathy
Oct 21, 2024 12:19 HKT/SGT
|
|
|
Ching Lee Holdings practices CSR to promote sustainability in the construction industry
Oct 21, 2024 11:12 HKT/SGT
|
|
|
JCB and GHL Expand Payment Options across Malaysia, Thailand and the Philippines
Oct 21, 2024 12:00 JST
|
|
|
China Medical System: First Ruxolitinib Cream's Prescriptions for Vitiligo Issued in the Greater Bay Area
Oct 21, 2024 10:00 HKT/SGT
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
